3D Bioprinting Functional Vascular Networks for Grafts

Erik Lundstrom^*
*Correspondence: Erik Lundstrom, Department of Tissue Bioengineering, Nordic Institute of Regenerative Science, Skarvik, Sweden, Email:

Introduction

The fabrication of functional vascular networks using bioprinting technologies represents a significant frontier in tissue engineering, aiming to address the critical need for viable, implantable vascular grafts. This field has witnessed substantial advancements in bioink formulation, sophisticated printhead designs, and optimized post-printing maturation strategies, all crucial for developing functional tissues. The primary objective is to overcome persistent challenges such as maintaining cell viability, ensuring structural integrity, and promoting angiogenic potential, thereby facilitating clinical translation for regenerative medicine applications [1].

Parallel to these technological advancements, the development of specialized bioinks has been a focal point for printing intricate vascular structures. The intrinsic material properties of these bioinks, including their printability, mechanical stability, and biocompatibility, are paramount for supporting cell survival and differentiation within the engineered construct. Researchers are actively investigating novel biomaterials and crosslinking methodologies that enable the creation of perfusable microchannels, a vital step towards achieving vascularization in engineered tissues [2].

A key strategy in overcoming vascularization hurdles involves integrating bioprinting techniques with the controlled release of angiogenic growth factors. This approach allows for the precise spatial and temporal delivery of signaling molecules within the printed construct, effectively promoting endothelial cell migration and capillary formation. Such controlled signaling is indispensable for ensuring adequate nutrient and oxygen supply to larger engineered tissues, a long-standing obstacle in the field [3].

Significant progress has also been made in developing advanced bioprinting systems, such as novel extrusion-based platforms, optimized for high-resolution printing of vascular networks. These systems are designed with meticulous attention to printhead considerations, including precise control over droplet size and printing speed, to achieve intricate vascular architectures that closely mimic native vasculature. This continuous innovation in printing hardware contributes to the development of more capable bioprinting platforms [4].

The current landscape of bioprinting for vascular tissue engineering is characterized by both notable successes and inherent limitations, necessitating critical examination. A persistent area of focus is the need for improved strategies for vascular maturation, encompassing mechanical stimulation and the utilization of perfusable bioreactor systems to enhance the functional integration of engineered vessels. Future research is directed towards incorporating diverse cell types and developing patient-specific vascular grafts [5].

Innovative techniques such as the use of sacrificial bioinks have emerged as a promising method for creating hollow channels that effectively mimic vascular lumens. This technique involves printing a temporary, degradable material that is subsequently removed, allowing for the formation of robust, perfusable structures. The approach shows great potential for fabricating complex vascular networks with precisely controlled diameters and interconnectivity, mirroring the intricate microvasculature of native tissues [6].

Laser-assisted bioprinting represents another powerful modality for creating highly precise vascular architectures. This technique offers distinct advantages in achieving exceptional cell viability and high spatial resolution, enabling the intricate patterning of microvascular networks. The ability to precisely deposit different cell types within the construct allows for the recapitulation of the multi-layered structure characteristic of natural blood vessels [7].

The development of vascularized tissue equivalents is significantly advanced by combining bioprinting with decellularized extracellular matrix (dECM). This biomimetic approach leverages the inherent biological cues within the dECM to guide cell behavior and promote vascularization. Successful printing of functional vascular channels within a dECM hydrogel demonstrates the potential of this method for creating more biologically relevant engineered tissues [8].

A critical aspect of engineered vascular grafts is their mechanical integrity and ability to withstand physiological pressures. Investigations into the mechanical properties of 3D bioprinted vascular constructs assess the impact of various bioink compositions and printing parameters on structural integrity and elasticity. Understanding these mechanical characteristics is paramount for ensuring the long-term functionality and successful integration of these grafts within the body [9].

Furthermore, the synergy between microfluidic techniques and bioprinting offers a powerful approach for fabricating perfusable vascular networks. This combined methodology allows for exquisite control over flow dynamics and cellular organization within the printed channels. The fabrication of microfluidic devices that effectively mimic capillary networks is crucial for advancing the in vitro study of endothelial cell function and angiogenesis [10].

Description

The field of vascular tissue engineering is profoundly impacted by advancements in bioprinting technologies, which are crucial for fabricating functional vascular networks. These technologies aim to create viable and implantable vascular grafts by focusing on key areas such as bioink formulation, sophisticated printhead design, and optimized post-printing maturation. Overcoming challenges related to cell viability, structural integrity, and angiogenic potential are central to enabling clinical translation for tissue regeneration [1].

The development of specialized bioinks tailored for printing vascular structures is a cornerstone of this research. These bioinks must possess optimal material properties, including excellent printability, robust mechanical stability, and high biocompatibility, to effectively support cell survival and differentiation. Ongoing research explores novel biomaterials and crosslinking strategies that are essential for constructing perfusable microchannels, a critical prerequisite for vascularizing engineered tissues [2].

To address the persistent challenge of vascularization in engineered tissues, researchers are integrating bioprinting with strategies for controlled release of angiogenic growth factors. This method allows for the precise localization and timed release of signaling molecules within the printed construct, thereby stimulating endothelial cell migration and promoting capillary network formation. This controlled biological signaling is vital for ensuring adequate nutrient and oxygen delivery to larger tissue constructs [3].

Advancements in bioprinting hardware are continuously contributing to the field, with novel extrusion-based systems being developed for high-resolution printing of vascular networks. These systems incorporate detailed design considerations for printheads, focusing on achieving precise control over droplet characteristics and printing speed. Such improvements enable the fabrication of intricate vascular architectures that more accurately replicate native vasculature, pushing the boundaries of bioprinting capabilities [4].

A comprehensive review of bioprinting for vascular tissue engineering highlights both the significant achievements and the remaining limitations. A key area of emphasis is the ongoing need for enhanced strategies for vascular maturation. This includes employing mechanical stimulation and utilizing perfusable bioreactor systems to improve the functional integration of engineered vascular grafts. Future directions are oriented towards incorporating diverse cell types and developing patient-specific solutions [5].

The utilization of sacrificial bioinks presents an innovative method for creating hollow channels that mimic vascular lumens. This technique involves printing a temporary, degradable material which is later removed, thereby forming stable and perfusable structures. This approach demonstrates considerable promise for fabricating complex vascular networks characterized by controlled diameters and interconnectivity, essential for replicating the microvasculature of natural tissues [6].

Laser-assisted bioprinting offers a precise method for constructing vascular architectures, characterized by its ability to achieve high cell viability and spatial resolution. This technology enables the intricate patterning of microvascular networks and facilitates the precise placement of different cell types. Such capabilities are crucial for recapitulating the multi-layered cellular organization found in native blood vessels [7].

Bioprinting approaches that incorporate decellularized extracellular matrix (dECM) are crucial for creating vascularized tissue equivalents. By utilizing the inherent biological cues present in dECM, this method promotes cellular behavior and vascularization. The successful printing of functional vascular channels within a dECM hydrogel underscores the potential of this technique to generate more biologically faithful engineered tissues [8].

Understanding the mechanical properties of 3D bioprinted vascular constructs is critical for their functional performance and integration. Studies are being conducted to assess how variations in bioink composition and printing parameters influence the structural integrity and elasticity of the fabricated vessels. This detailed characterization is essential for ensuring the long-term viability and efficacy of engineered vascular grafts [9].

The integration of microfluidic principles with bioprinting technologies provides a powerful means to fabricate perfusable vascular networks. This combined approach offers precise control over fluid dynamics and cellular organization within the printed channels. The development of microfluidic devices that mimic capillary networks is instrumental in advancing the in vitro study of endothelial cell function and angiogenesis [10].

Conclusion

This body of research explores the cutting-edge field of vascular tissue engineering, focusing on the application of 3D bioprinting technologies to create functional vascular networks. Key advancements include novel bioink formulations, sophisticated printing systems, and strategies for promoting vascularization, such as controlled release of growth factors and the use of sacrificial bioinks. Techniques like laser-assisted bioprinting and the incorporation of decellularized extracellular matrix are also discussed for their ability to create intricate and biologically relevant vascular structures. Emphasis is placed on addressing challenges in cell viability, structural integrity, and mechanical properties to enable the clinical translation of engineered vascular grafts. Future directions involve optimizing vascular maturation and developing patient-specific solutions.

Acknowledgement

None

Conflict of Interest

None

References

Jihua Zhang, Haozhi Wang, Yingying Zhang.. "Recent Advances in 3D Bioprinting of Vascular Tissues".Ann. Biomed. Eng. 49 (2021):1332-1346.

Indexed at, Google Scholar, Crossref

Zheng Zhang, Yiran Wang, Jie Song.. "Bioinks for 3D Bioprinting: An Overview".Adv. Healthc. Mater. 10 (2021):2001717.

Indexed at, Google Scholar, Crossref

Yuan Wen, Saurabh Kumar, Xingyu Chen.. "3D Bioprinting of Vascularized Tissues: Current Strategies and Future Perspectives".Biofabrication 12 (2020):042001.

Indexed at, Google Scholar, Crossref

Jun Wang, Qianqian Li, Hongwei Wang.. "High-Resolution 3D Bioprinting of Vascular Networks Using a Novel Extrusion-Based System".Biomaterials 285 (2022):121524.

Indexed at, Google Scholar, Crossref

Shengdi Hu, Xianyun Tang, Yang Li.. "Bioprinting Vascularized Tissues: From Bench to Bedside".Cells 12 (2023):1800.

Indexed at, Google Scholar, Crossref

Jiajia Wang, Yonggang Lei, Huiyuan Deng.. "Sacrificial Bioinks for Printing Perfusable Vascular Channels".Adv. Funct. Mater. 32 (2022):2107640.

Indexed at, Google Scholar, Crossref

Yan Li, Mengru Li, Zhenguo Jiang.. "Laser-Assisted Bioprinting for Vascular Tissue Engineering".Int. J. Mol. Sci. 21 (2020):10113.

Indexed at, Google Scholar, Crossref

Chaozong Liu, Ying Li, Yingjian Liu.. "Bioprinting of Vascularized Tissue Constructs Using Decellularized Extracellular Matrix".Tissue Eng. Part A 27 (2021):343-355.

Indexed at, Google Scholar, Crossref

Shuai Wang, Yuanzhe Li, Mingyu Gao.. "Mechanical Characterization of 3D Bioprinted Vascular Constructs".Mater. Today Bio 20 (2023):100840.

Indexed at, Google Scholar, Crossref

Junjie Yang, Chenglin Li, Jianhua Li.. "Microfluidic-Assisted 3D Bioprinting of Vascular Networks".Lab Chip 22 (2022):2375-2386.

Indexed at, Google Scholar, Crossref